亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

CAS70458-95-6 甲磺酸培氟沙星

 
 
單價 500.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 10000kg起訂25kg
品牌 yc
型號 70458-95-6
規格 99%
過期 長期有效
更新 2013-11-08 08:59
 

湖北武漢遠成共創科技有限公司銷售部

企業會員第13年
資料未認證
保證金未繳納
詳細說明

甲磺酸培氟沙星 
化學名: 1-乙基-6-氟-7-(4-甲基哌嗪基)-4-氧代-1,4-二氫喹啉-3-羧酸甲磺酸鹽
CAS 登錄號  70458-95-6
英文名  Pefloxacin
mesylate
分 子 式: C17H20FN3O3
分子量  429.46
含    量: 99%
  中文名稱 甲磺酸培氟沙星
英文名稱 3-carboxy-1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline monomethanesulphonate
中文別名 1-乙基-6-氟-7-(4-甲基哌嗪基)-4-氧代-1,4-二氫喹啉-3-羧酸甲磺酸鹽
CAS RN 70458-95-6
EINECS號 274-613-9
分 子 式 C18H24FN3O6S
分 子 量 429.4631

產品用途:抗生素藥,用于治療大腸桿菌、痢疾桿菌、流感桿菌、金黃色葡萄球菌等感染 
藥效學:“甲磺酸培氟沙星”為第三代喹諾酮類抗菌新藥,其抗菌譜廣,對大腸桿菌、克雷白菌屬、變形桿菌、志賀菌屬、傷寒沙門菌屬等以及流感桿菌、
奈瑟菌屬等具有強大抗菌活性,對革蘭氏陽性菌、金黃色葡萄球菌和綠膿桿菌具有一定抗菌作作用。本品為殺菌劑 ,作用機制為抑制細菌DNA螺旋酶。
包    裝:25公斤/紙板桶。

舉報收藏 0評論 0
更多>本企業其它產品
現貨供應α-己基桂醛 現貨供應鄰氟肉桂醛 供應氯諾昔康 供應氯諾昔康 現貨供應 4-氟肉桂醛 供應3-吲哚乙酸 供應卡波姆934P 銷售物美價廉原料藥氨芐西林鈉
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |